Buy & Sell Millennium Pharmacon International Tbk. - SDPC Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp4.11T | +4.93% |
| Cost of Revenue | Rp3.75T | +4.6% |
| Gross Profit | Rp362.36B | +8.37% |
| General Expenses, Depreciation, Interest | Rp234.9B | +3.85% |
| Operating Profit | Rp127.46B | +17.82% |
| Other Income | -Rp78.57B | -2.38% |
| EBT | Rp48.9B | +76.51% |
| Taxes | -Rp10.43B | -3.3% |
| Net Income | Rp38.47B | +127.24% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp1.96T | +10.66% |
| Total Liabilities | Rp1.65T | +10.47% |
| Total Equity | Rp315.42B | +11.65% |
| Total Liabilities & Total Equity | Rp1.96T | +10.66% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp88.1B | -170.22% |
| CF from Investment | Rp38.64B | +177.54% |
| CF from Financing | Rp40.09B | -129.93% |
| Net Cash Flow | Rp9.37B | -272.66% |